1 – 15 of 51
- show: 15
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2019
-
Mark
The impact of body size changes on recurrence risk depends on age and estrogen receptor status in primary breast cancer
(
- Contribution to journal › Article
-
Mark
Patients' and physicians' disagreement on patients' understanding of clinical cancer trial information : A pairwise pilot study of mirroring subjective assessments compared with objective measurements
(
- Contribution to journal › Article
- 2018
-
Mark
Interactions between ABCB1genotype and preoperative statin use impact clinical outcomes among breast cancer patients
(
- Contribution to journal › Article
-
Mark
Patients' reasoning regarding the decision to participate in clinical cancer trials : an interview study
(
- Contribution to journal › Article
-
Mark
Increasing preoperative body size in breast cancer patients between 2002 and 2016 : implications for prognosis
(
- Contribution to journal › Article
-
Mark
Stellate cells and mesenchymal stem cells in benign mammary stroma are associated with risk factors for breast cancer - an observational study
(
- Contribution to journal › Article
-
Mark
Coffee is associated with lower breast tumor insulin-like growth factor receptor 1 levels in normal-weight patients and improved prognosis following tamoxifen or radiotherapy treatment
(
- Contribution to journal › Article
-
Mark
Current smoking is associated with a larger waist circumference and a more androgenic profile in young healthy women from high-risk breast cancer families
(
- Contribution to journal › Article
- 2017
-
Mark
Högt ER-beta-uttryck starkt skyddande mot återfall hos de kvinnor som fått cytostatika
(
- Contribution to specialist publication or newspaper › Specialist publication article
-
Mark
Östrogenreceptor-beta kopplad till bättre prognos vid bröstcancer
(
- Contribution to journal › Article
-
Mark
Combined and individual tumor-specific expression of insulinlike growth factor-I receptor, insulin receptor and phosphoinsulin- like growth factor-I receptor/insulin receptor in primary breast cancer : Implications for prognosis in different treatment groups
(
- Contribution to journal › Article
-
Mark
The prognostic impact of COX-2 expression in breast cancer depends on oral contraceptive history, preoperative NSAID use, and tumor size
(
- Contribution to journal › Article
-
Mark
High Estrogen Receptor β Expression Is Prognostic among Adjuvant Chemotherapy-Treated Patients-Results from a Population-Based Breast Cancer Cohort
(
- Contribution to journal › Article
-
Mark
Body mass index influences the prognostic impact of combined nuclear insulin receptor and estrogen receptor expression in primary breast cancer
(
- Contribution to journal › Article
-
Mark
Androgen receptor expression and breast cancer mortality in a population-based prospective cohort
(
- Contribution to journal › Article